Physiomics (RVW1) Financial Statements
Physiomics Financial Overview
Physiomics's market cap is currently $2.31M. The company's EPS TTM is $-0.00; its P/E ratio is -2.13; Physiomics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 941.22K | $ 784.00K | $ 543.25K | $ 597.35K | $ 830.27K |
| Gross Profit | $ -797.20K | $ -435.08K | $ -677.43K | $ -581.62K | $ -429.01K |
| Operating Income | $ -797.20K | $ -457.79K | $ -670.82K | $ -573.73K | $ -359.11K |
| EBITDA | $ -788.31K | $ -448.21K | $ -659.80K | $ -561.57K | $ -347.84K |
| Net Income | $ -697.03K | $ -415.25K | $ -609.35K | $ -477.26K | $ -253.14K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 418.63K | $ 461.24K | $ 191.07K | $ 416.59K | $ 687.67K |
| Total Assets | $ 788.55K | $ 892.03K | $ 422.60K | $ 674.39K | $ 1.12M |
| Total Debt | $ 0.00 | $ 0.00 | $ 3.83K | $ 7.35K | $ 0.00 |
| Net Debt | $ -418.63K | $ -461.24K | $ -191.07K | $ -416.59K | $ -687.67K |
| Total Liabilities | $ 264.57K | $ 199.85K | $ 140.08K | $ 142.67K | $ 140.61K |
| Stockholders' Equity | $ 523.98K | $ 692.17K | $ 282.53K | $ 531.72K | $ 974.81K |
| Cash Flow | |||||
| Free Cash Flow | $ -566.17K | $ -550.08K | $ -565.44K | $ -271.50K | $ -358.62K |
| Operating Cash Flow | $ -561.74K | $ -546.14K | $ -548.13K | $ -264.86K | $ -349.25K |
| Investing Cash Flow | $ -4.43K | $ -3.41K | $ -15.21K | $ -6.22K | $ -9.37K |
| Financing Cash Flow | $ 523.56K | $ 819.73K | $ 337.83K | $ 0.00 | $ 2.85K |
Currency in GBP
